Brief: Hemcheck Sweden Appoints Jesper Birgemo As CEO
Nov 28 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* APPOINTS JESPER BIRGEMO AS CEO
* JOEN AVERSTAD, WHO HAS SERVED AS ACTING CEO, WILL CONTINUE
TO
WORK WITH THE COMPANY IN THE ROLE OF CFO FROM NOVEMBER 28
* JESPER BIRGEMO TAKES OVER AS NEW CEO AS OF TODAY, NOVEMBER
28
2023
Source text for Eikon: ID:nWkr582JQr
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln